Cargando…
The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma
Immunotherapy has remarkably revolutionized the management of advanced HCC and prompted clinical trials, with therapeutic agents being used to selectively target immune cells rather than cancer cells. Currently, there is great interest in the possibility of combining locoregional treatments with imm...
Autores principales: | Brandi, Nicolò, Renzulli, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217839/ https://www.ncbi.nlm.nih.gov/pubmed/37239941 http://dx.doi.org/10.3390/ijms24108598 |
Ejemplares similares
-
Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021) -
Radiological findings in non-surgical recurrent hepatocellular carcinoma: From locoregional treatments to immunotherapy
por: Ippolito, Davide, et al.
Publicado: (2023) -
Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy
por: Han, Ji-Won, et al.
Publicado: (2021) -
Friend or Foe? Locoregional Therapies and Immunotherapies in the Current Hepatocellular Treatment Landscape
por: Young, Shamar, et al.
Publicado: (2023) -
How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their Roles
por: Fu, Yan, et al.
Publicado: (2023)